Navigation Links
Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease
Date:5/23/2013

l needs and typically provides priority review status.

"Cognitive impairment is a hallmark of Huntington's disease and schizophrenia, and there currently are no drugs that improve cognition in either disorder," stated Gregory A. Demopulos , M.D., chairman and chief executive officer of Omeros. "In Huntington's disease, OMS824 also has the potential to improve motor control and to reduce the rate of neurodegeneration, slowing disease progression. We are pleased that the FDA has now cleared the way for us to evaluate OMS824 in both patients with Huntington's disease and schizophrenia, and we look forward to initiating enrollment in our Phase 2 clinical trials."

About Orphan Drug Status
Orphan drug designation is granted by the FDA's Office of Orphan Products Development for drugs that are expected to provide significant therapeutic advantage over existing treatments and that target conditions affecting 200,000 or fewer U.S. patients annually. Orphan drug designation qualifies a company for several benefits under the Orphan Drug Act of 1983. The benefits apply across all stages of drug development and include accelerated approval process; seven years of market exclusivity following marketing approval; tax credits on U.S. clinical trials; eligibility for orphan drug grants; and waiver of certain administrative fees.

About FDA's Fast Track Program
The FDA's Fast Track program facilitates the development of drugs intended to treat serious or life-threatening conditions and that have the potential to address unmet medical needs. Fast Track drugs are eligible for more frequent and timely meetings with the FDA to discuss the development plan and to ensure that data needed for approval are collected appropriately. Drugs in the Fast Track program typically are granted priority review status and their respective New Drug Applications are accepted and reviewed by the FDA as rolling submissions.

About Omeros' PDE1
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
2. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
3. Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
4. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
5. AbbVies Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
6. Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia
7. Bayers Investigational Riociguat Granted U.S. FDA Priority Review for Pulmonary Arterial Hypertension and Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
8. Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013
9. European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Companys empagliflozin*, an investigational type 2 diabetes treatment
10. Boehringer Ingelheim and Eli Lilly and Company submit new drug application to FDA for empagliflozin, an investigational type 2 diabetes treatment
11. Genocea Publishes Preclinical Data For Investigational Vaccine Candidate For HSV-2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014  According to their CEO, Rob ... trials is going through a complete transformation with ... of the current clinical trial management process isn,t ... clinical trials, which will ultimately drive the prescription ... company has been recognized by the National Cancer ...
(Date:9/30/2014)... 30, 2014   Easy Breathe , the fastest ... announced that it now offers the revolutionary AirSense ... the first sleep apnea therapy devices with internal cellular ... to track and share real-time data on each user,s ... CPAP therapy.  In addition, the internal modem allows the ...
(Date:9/30/2014)... Quebec , Sept. 30, 2014 Valeant ... TSX: VRX) today announced that the company,s ... Letter from the U.S. Food and Drug Administration (FDA) ... Company,s records with regards to Sculptra Aesthetic injectable, which ... Warning Letter pertains to the management of Valeant,s contract manufacturers ...
Breaking Medicine Technology:Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 3Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 4Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2
... National Parkinson Foundation (NPF) and the ... to evaluate Kinetic,s Objective Parkinson,s Disease Measurement (OPDM) system ... of Parkinson,s disease (PD).  The evaluation will take place ... groundbreaking Quality Improvement Initiative (QII). "It ...
... AT&T * and Zephyr Technology today announced ... to the next generation of the Zephyr BioHarness™ designed ... breathing rate, skin temperature, then contextualize the information with ... is then viewed through the Zephyr portal or pushed ...
Cached Medicine Technology:Kinetics Foundation and National Parkinson Foundation (NPF) Announce their Partnership to Evaluate Objective Parkinson's Disease Measurement System 2Kinetics Foundation and National Parkinson Foundation (NPF) Announce their Partnership to Evaluate Objective Parkinson's Disease Measurement System 3AT&T to Wirelessly Connect Zephyr BioHarness 2AT&T to Wirelessly Connect Zephyr BioHarness 3AT&T to Wirelessly Connect Zephyr BioHarness 4
(Date:10/1/2014)... 01, 2014 Join the more than 80 ... Treatment Center’s first ever charity golf tournament to benefit Project ... eating disorders who cannot afford treatment. The tournament will be ... Eureka, Mo. , The day-long event starts with 10:30 ... and award dinner will begin at 5 p.m. and will ...
(Date:10/1/2014)... Beverly Hills, California (PRWEB) October 01, 2014 ... relationship expert, Dr. Kathleen Mojas is celebrating 20 years ... she has assisted hundreds of people to achieve greater ... released an important list of warning signs and suggestions ... relationship. , Dr. Mojas explains: “Believe it or ...
(Date:10/1/2014)... Jupiter, FL (PRWEB) October 01, 2014 ... Begley, Jr., scheduled to broadcast on Monday, October 20, ... In this episode, Innovations will go behind the scenes ... prevention programs. This segment will explore the practical help ... young adults, which teaches the warning signs of abuse, ...
(Date:10/1/2014)... Inc., announced today their new NoteSwift™ 2.0 for Allscripts ... the bridge between the EHR and Dragon Medical interpreting ... at the point of care. NoteSwift reduces the time ... than half – and virtually eliminates mouse clicks – ... EHR use according to the June 12, 2014 HIMSS ...
(Date:10/1/2014)... Scientists at the University of Western ... immune system proteins has the power to knock out ... of the new study on their website. Click ... in the UWA School of Pathology and Laboratory Medicine ... with mesothelioma with promising results. , “A timed ...
Breaking Medicine News(10 mins):Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 3Health News:Innovations to Explore Breakthroughs in Health and Wellness in Upcoming Episode Airing Monday, October 20, 2014 via Discovery Channel 2Health News:NoteSwift Joins Allscripts Developer Program 2Health News:NoteSwift Joins Allscripts Developer Program 3Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2
... a biotech lab in Korea. He was told that he was ... pet dog, his beloved family mutt, Missy. Now one year old, ... the good life in Mill Valley, California. “Not only does she ... same, and she has some of the same quirks that made ...
... become standard, researchers say , , FRIDAY, Dec. 5 (HealthDay ... better determine whether a breast lesion detected by MRI ... unnecessary biopsies, say U.S. researchers. , They reviewed almost ... the Seattle Cancer Care Alliance and identified three important ...
... Sense, Will Stimulate Economy, Save Lives , ... Administration,s proposed truck clean-up rule, which the California Air Resources ... much-needed boost to the economy and cut billions of dollars ... Californians. , , "The ...
... 6 months appears most effective, Australian study finds , , ... possible to control the progression of cystic fibrosis through ... infants, according to Australian researchers. , They found that ... early as infancy, even though lung function shortly after ...
... December 5, 2008 REGiMMUNE Corporation, a ... and products for immune disorders, will present preclinical ... Graft versus Host Disease (GvHD) at the American ... 6 through 9 in San Francisco, California. REGiMMUNE ...
... Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced Lauren ... in a panel discussion on "Adapting Specialty Pharma Strategy to ... panel will begin at 10:00 a.m. Eastern Time on Wednesday, ... , To access the live ...
Cached Medicine News:Health News:Cloned Canine Celebrates Her 1st Birthday 2Health News:New Statistical Model Could Cut Needless Breast Biopsies 2Health News:Proposed Truck Clean-Up Rule Will Save Billions in Health-Related Costs for Truckers and Other Californians 2Health News:Aggressive Therapy May Stem CF Progression in Infants 2
... IS2s DCC camera is optimized for cardiac imaging ... dual-view planar studies. Resolution and image quality are ... to the front of the gantry is clear ... bicycles or treadmills for dual view gated cardiac ...
... optimum head hyperextension, open airway, and a firm ... at strategic locations throughout the hospital, the Thumper ... immediately, and easy conversion to Thumper CPR ... done in less than 30 seconds. ,Slide the ...
... The Paradigm Pachymetric Analyzer is designed ... employing unique digital signal processing algorithms. During ... a reading if the probe is +1.5 ... assured of highly accurate results, every time. ...
NIDEK's US-1800 is an industry leader offering both combination pachymeter and ultrasound functionalities. The unit features and includes the latest IOL power calculation software, a touch screen pan...
Medicine Products: